The research involves a system of sensors that monitor gait. Credit: The University of Sheffield.

A research team at the University of Sheffield has secured funding to develop a monitoring system to assess a patient’s health and wellbeing based on their gait.

Comprising an array of small sensors, the technology is expected to be used to observe the effects of diseases such as Parkinson’s, chronic obstructive pulmonary disease (COPD), multiple sclerosis, proximal femoral fracture and congestive heart failure.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Poor gait is also linked to cognitive decline, dementia, higher risk of falls, greater disease risk and earlier death.

The €2.1m grant will be provided by the European Innovative Medicines Initiative 2 Joint Undertaking.

“MOBILISE-D is the product of a long-standing multidisciplinary collaboration between researchers at the Insigneo Institute for in silico Medicine and the NIHR Sheffield Biomedical Research Centre.”

The research forms part of the European MOBILISE-D project, which aims to use digital technology to assess mobility loss while facilitating improved clinical trials and management.

Under the project, clinicians and scientists from academic centres in Europe will work with European Federation of Pharmaceutical Industries and Associations (EFPIA) member companies.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

A total of 34 organisations are participating in the research, including the Insigneo Institute, which is led by the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust.

The Insigneo Institute director and the university’s department of mechanical engineering professor Claudia Mazzà will lead the development of the digital monitoring technology.

Mazzà said: “MOBILISE-D is the product of a long-standing multidisciplinary collaboration between researchers at the Insigneo Institute for in silico Medicine and the NIHR Sheffield Biomedical Research Centre.

“It marks a fantastic opportunity for the University of Sheffield and Sheffield Teaching Hospital to contribute to a technology-based revolution in clinical management and personalised healthcare, with a local focus on multiple sclerosis.”

Sheffield Teaching Hospitals professor Basil Sharrack is set to lead the clinical validation of the technology in multiple sclerosis.